Walsh & Associates’s Patterson-UTI PTEN Stock Holding History

Walsh & Associates’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23	Closed	-$249	–	283
2026 Q1	$249	Buy	+23	New	+$197	﹤0.01%	261

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Walsh & Associates's PTEN Position: Q2 2026 in Review

Walsh & Associates sold out of Patterson-UTI (PTEN) in Q2 2026, closing a stake of 23 shares — an estimated $249 sold.

Walsh & Associates first reported a position in PTEN in Q1 2026 and held it in 1 quarter. The position peaked at $249 in Q1 2026. 434 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

Walsh & Associates reported no remaining Patterson-UTI position as of Q2 2026 after selling out during the quarter.
Walsh & Associates sold 23 Patterson-UTI shares in Q2 2026, an estimated $249.
Walsh & Associates first reported a position in Patterson-UTI in Q1 2026 and held it in 1 quarter.
Walsh & Associates's Patterson-UTI position peaked at $249 in Q1 2026.
434 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Walsh & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.